{"id":"https://openalex.org/W2162129397","doi":"https://doi.org/10.1136/bmjopen-2012-002080","title":"Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study","display_name":"Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study","alternate_titles":[],"publication_year":2013,"publication_date":"2013-01-07","ids":{"openalex":"https://openalex.org/W2162129397","doi":"https://doi.org/10.1136/bmjopen-2012-002080","mag":"2162129397","pmid":"https://pubmed.ncbi.nlm.nih.gov/23299113","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3549220"},"language":"en","primary_location":{"id":"doi:10.1136/bmjopen-2012-002080","doi":"https://doi.org/10.1136/bmjopen-2012-002080","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjopen-2012-002080","pdf_url":"https://bmjopen.bmj.com/content/bmjopen/3/1/e002080.full.pdf","source":{"id":"https://openalex.org/S79054089","display_name":"BMJ Open","issn_l":"2044-6055","issn":["2044-6055"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2162129397"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmjopen.bmj.com/content/bmjopen/3/1/e002080.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5107924007","display_name":"Carlos Mart\u00ednez","orcid":"https://orcid.org/0000-0001-6498-6428","observed_orcids":["https://orcid.org/0000-0001-6498-6428"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Carlos Martinez","raw_affiliation_strings":["Independent pharmacoepidemiologist, Im Dinkelfeld 32, 60388 Frankfurt, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Independent pharmacoepidemiologist, Im Dinkelfeld 32, 60388 Frankfurt, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048018080","display_name":"Roy W. Jones","orcid":"https://orcid.org/0000-0002-7953-5985","observed_orcids":["https://orcid.org/0000-0002-7953-5985"]},"institutions":[{"id":"https://openalex.org/I2800549715","display_name":"Royal United Hospital","ror":"https://ror.org/00a858n67","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800549715","https://openalex.org/I4210161895"]},{"id":"https://openalex.org/I4210110590","display_name":"The Research Institute for the Care of Older People","ror":"https://ror.org/01px69d78","country_code":"GB","type":"other","lineage":["https://openalex.org/I4210110590"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Roy W Jones","raw_affiliation_strings":["Research Institute for the Care of Older People, Royal United Hospital, Bath, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Institute for the Care of Older People, Royal United Hospital, Bath, UK","institution_ids":["https://openalex.org/I2800549715","https://openalex.org/I4210110590"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050717751","display_name":"Stephan Rietbrock","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephan Rietbrock","raw_affiliation_strings":["Independent pharmacoepidemiologist, Im Dinkelfeld 32, 60388 Frankfurt, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Independent pharmacoepidemiologist, Im Dinkelfeld 32, 60388 Frankfurt, Germany","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5107924007"],"corresponding_institution_ids":[],"apc_list":{"value":1500,"currency":"GBP","value_usd":1839},"apc_paid":{"value":1500,"currency":"GBP","value_usd":1839},"fwci":6.3229,"has_fulltext":true,"cited_by_count":104,"citation_normalized_percentile":{"value":0.97366452,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"3","issue":"1","first_page":"e002080","last_page":"e002080"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.035100001841783524,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10272","display_name":"Mental Health Treatment and Access","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dementia","display_name":"dementia","score":0.9829999804496765},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8019999861717224},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.9430000185966492},{"id":"https://openalex.org/keywords/hypnotics","display_name":"hypnotics","score":0.9570000171661377},{"id":"https://openalex.org/keywords/anxiolytics","display_name":"anxiolytics","score":1.0},{"id":"https://openalex.org/keywords/acetylcholinesterase-inhibitors","display_name":"acetylcholinesterase inhibitors","score":0.984000027179718},{"id":"https://openalex.org/keywords/memantine","display_name":"memantine","score":1.0},{"id":"https://openalex.org/keywords/anti-dementia-drugs","display_name":"anti-dementia drugs","score":0.746999979019165},{"id":"https://openalex.org/keywords/prescribing-trends","display_name":"prescribing trends","score":0.7609999775886536},{"id":"https://openalex.org/keywords/community-dwelling-patients","display_name":"community-dwelling patients","score":0.7080000042915344},{"id":"https://openalex.org/keywords/drug-use-patterns","display_name":"drug use patterns","score":0.3959999978542328},{"id":"https://openalex.org/keywords/clinical-practice-research-datalink","display_name":"Clinical Practice Research Datalink","score":0.7730000019073486},{"id":"https://openalex.org/keywords/united-kingdom","display_name":"United Kingdom","score":0.39800000190734863}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8465175032615662},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.8331528902053833},{"id":"https://openalex.org/C2779484449","wikidata":"https://www.wikidata.org/wiki/Q412189","display_name":"Memantine","level":4,"score":0.7683393955230713},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6802390217781067},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.648712158203125},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5002992153167725},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.4569379389286041},{"id":"https://openalex.org/C2776332859","wikidata":"https://www.wikidata.org/wiki/Q411887","display_name":"Rivastigmine","level":5,"score":0.43853509426116943},{"id":"https://openalex.org/C2779056891","wikidata":"https://www.wikidata.org/wiki/Q412690","display_name":"Galantamine","level":5,"score":0.41116029024124146},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3800668716430664},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3551607131958008},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.29164934158325195},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.21523761749267578},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.19055435061454773}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1136/bmjopen-2012-002080","doi":"https://doi.org/10.1136/bmjopen-2012-002080","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjopen-2012-002080","pdf_url":"https://bmjopen.bmj.com/content/bmjopen/3/1/e002080.full.pdf","source":{"id":"https://openalex.org/S79054089","display_name":"BMJ Open","issn_l":"2044-6055","issn":["2044-6055"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2552012","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3549220","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3549220","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3549220/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open","raw_type":"Text"},{"id":"pmid:23299113","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23299113","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ open","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1136/bmjopen-2012-002080","doi":"https://doi.org/10.1136/bmjopen-2012-002080","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjopen-2012-002080","pdf_url":"https://bmjopen.bmj.com/content/bmjopen/3/1/e002080.full.pdf","source":{"id":"https://openalex.org/S79054089","display_name":"BMJ Open","issn_l":"2044-6055","issn":["2044-6055"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320327810","display_name":"Merz Pharmaceuticals","ror":"https://ror.org/025f1e779"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2162129397.pdf","grobid_xml":"https://content.openalex.org/works/W2162129397.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W123303041","https://openalex.org/W261910342","https://openalex.org/W1688235741","https://openalex.org/W1923760566","https://openalex.org/W1962254068","https://openalex.org/W1968750846","https://openalex.org/W1987307065","https://openalex.org/W1991168471","https://openalex.org/W1992109356","https://openalex.org/W2007453084","https://openalex.org/W2008800000","https://openalex.org/W2023068500","https://openalex.org/W2044170764","https://openalex.org/W2087962343","https://openalex.org/W2088361570","https://openalex.org/W2099833638","https://openalex.org/W2108221994","https://openalex.org/W2110132657","https://openalex.org/W2132592055","https://openalex.org/W2132871355","https://openalex.org/W2136332296","https://openalex.org/W2139046272","https://openalex.org/W2139214514","https://openalex.org/W2139560403","https://openalex.org/W2143521222","https://openalex.org/W2151585937","https://openalex.org/W2154596951","https://openalex.org/W2168558795","https://openalex.org/W2171122345"],"related_works":["https://openalex.org/W7099319915","https://openalex.org/W2184896656","https://openalex.org/W2048533027","https://openalex.org/W2141191339","https://openalex.org/W2049268457","https://openalex.org/W2090887175","https://openalex.org/W2022864154","https://openalex.org/W2259503639","https://openalex.org/W2120962321","https://openalex.org/W2008380773"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"investigate":[2],"the":[3,36,237,249,299],"pattern":[4],"and":[5,13,18,21,49,51,60,74,85,92,98,105,123,134,171,187,206,215,219,222,224,243],"trends":[6],"of":[7,9,62,70,81,111,132,136,141,150,185,204,208,232,301],"use":[8,80,110,143,169,184,231,264,275,297],"antipsychotics,":[10,82,213],"antidepressants,":[11,83,217],"hypnotics":[12,84],"anxiolytics":[14,86,188,221],"in":[15,22,35,157,161,167,175,192,200,236,273,276,288,295],"Alzheimer's":[16],"disease":[17],"other":[19],"dementias":[20],"patients":[23,33,118],"treated":[24],"with":[25,31,44,119],"antidementia":[26],"medications.":[27],"DESIGN:":[28],"Cohort":[29],"study":[30,77],"dementia":[32,63,96,121,151,277],"formed":[34],"UK":[37],"Clinical":[38],"Practice":[39],"Research":[40],"Datalink.":[41],"Participants":[42],"Patients":[43],"incident":[45,120],"dementia,":[46],"between":[47],"1995":[48,145,158],"2011":[50,147],"a":[52,172,182,190,198,259,285,293],"reference":[53],"non-dementia":[54],"cohort":[55,180],"matched":[56,126,179],"on":[57,148],"age,":[58],"gender":[59],"date":[61],"diagnosis.":[64],"Two":[65],"subcohorts":[66],"included":[67],"new":[68],"users":[69,131,210,253],"acetylcholinesterase":[71],"inhibitors":[72],"(AChEIs)":[73],"memantine.":[75,114,137,302],"The":[76,138,178,227,270],"endpoint":[78],"was":[79,152,164,284,292],"up":[87,100,240],"to":[88,101,146,159,241,255,279],"10":[89,128],"years":[90,94,103],"before":[91,104],"4":[93],"after":[95,108,246,298],"diagnosis,":[97],"for":[99,229,251,266],"5":[102],"1":[106],"year":[107,238],"first":[109],"AChEI":[112,133,205,242,252],"or":[113],"RESULTS:":[115],"50":[116,124],"349":[117,125],"diagnosis":[122,149],"controls,":[127],"794":[129],"first-time":[130],"669":[135],"mean":[139],"prevalence":[140],"antipsychotic":[142,263,274,296],"from":[144,155],"12.5%,":[153],"decreasing":[154],"19.9%":[156],"7.4%":[160],"2011.":[162],"There":[163,291],"an":[165],"increase":[166,174,256,287],"antidepressant":[168,289],"(10.7-26.3%)":[170],"small":[173],"anxiolytic":[176],"use.":[177,202,290],"showed":[181,197],"lower":[183],"antipsychotics":[186,233],"but":[189,257],"rise":[191],"antidepressants":[193],"(5.9-13.4%).":[194],"Both":[195],"groups":[196],"decrease":[199],"hypnotic":[201],"10.6%":[203],"26.3%":[207,216],"memantine":[209,244,267],"were":[211,234],"prescribed":[212],"34.1%":[214],"13.2%":[218],"4.1%":[220],"18.4%":[223],"8.3%":[225],"hypnotics.":[226],"slopes":[228],"monthly":[230],"positive":[235],"leading":[239],"use;":[245],"treatment":[247],"initiation":[248,300],"slope":[250],"continued":[254],"at":[258],"reduced":[260],"rate":[261],"whereas":[262],"declined":[265],"users.":[268],"CONCLUSIONS:":[269],"marked":[271],"reduction":[272],"is":[278],"be":[280],"welcomed":[281],"while":[282],"there":[283],"steady":[286],"decline":[294]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2162129397","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
